{
  "id": "624f2355e764a5320400000b",
  "type": "yesno",
  "question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?",
  "ideal_answer": "Conclusion. The German-SNOT-22 validated here matches the original SNOT-22. It is a reliable, valid and responsive questionnaire to assess symptoms, HRQOL and treatment-response in CRS-patients.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26228968",
    "http://www.ncbi.nlm.nih.gov/pubmed/30156212",
    "http://www.ncbi.nlm.nih.gov/pubmed/33657861",
    "http://www.ncbi.nlm.nih.gov/pubmed/19793277",
    "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
    "http://www.ncbi.nlm.nih.gov/pubmed/31306495",
    "http://www.ncbi.nlm.nih.gov/pubmed/34182821",
    "http://www.ncbi.nlm.nih.gov/pubmed/33271403",
    "http://www.ncbi.nlm.nih.gov/pubmed/25323055",
    "http://www.ncbi.nlm.nih.gov/pubmed/31608679",
    "http://www.ncbi.nlm.nih.gov/pubmed/28753732",
    "http://www.ncbi.nlm.nih.gov/pubmed/33906469",
    "http://www.ncbi.nlm.nih.gov/pubmed/34585521",
    "http://www.ncbi.nlm.nih.gov/pubmed/34196397",
    "http://www.ncbi.nlm.nih.gov/pubmed/26610073",
    "http://www.ncbi.nlm.nih.gov/pubmed/25195715"
  ],
  "snippets": [
    {
      "text": "The Sino-Nasal-Outcome-Test-22 (SNOT-22) represents the reference questionnaire to assess symptoms, health-related quality-of-life (HRQOL) and treatment-response in patients with chronic rhinosinusitis (CRS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271403",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271403",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " Patients meeting diagnostic criteria for CRS were prospectively enrolled in a cross-sectional study. Responses from the Sinonasal Outcomes Test-22 (SNOT-22), a measure of patient HRQOL, as well as the Lund-Kennedy and Lund-Mackay scores were recorded at enrollment",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33906469",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Three groups of 12 participants each were examined: patients with CRS without polyposis (CRS group), patients with symptoms of CRS but radiologically normal sinuses (symptoms-only), and healthy controls. Measurements of nNO were carried out using aspiration method and humming maneuver. All participants completed the Sino-Nasal Outcome Test (SNOT-22).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31608679",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: The Sino-Nasal-Outcome-Test-22 (SNOT-22) represents the reference questionnaire to assess symptoms, health-related quality-of-life (HRQOL) and treatment-response in patients with chronic rhinosinusitis (CRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33271403",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "tcomes included scores on the CRS disease severity visual analog scale (VAS), 22-item Sino-Nasal Outcome Test (SNOT-22), 5-dimension EuroQoL (EQ-5D) general health status VAS, and 36-item Short-Form Health Survey (SF-36) for HRQoL and nasal polyp-related healthcare resource use questionnaires.RE",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31306495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: The 22-item Sino-Nasal Outcome Test (SNOT-22) is a commonly utilized outcome measure for chronic rhinosinus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26610073",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: The 22-item sino-nasal outcome test (SNOT-22) is a widely used and powerful patient-reported outcomes measure for chronic rhinosinus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34585521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinus",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25323055",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES/HYPOTHESIS: Sinonasal Outcomes Test-22 (SNOT-22) is used widely as a patient-reported sinonasal quality-of-life (QOL) instrument for endoscopic endonasa",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34196397",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Is sino-nasal outcome test-22 reliable for guiding chronic rhinosinusitis patients for endoscopic sinus surgery",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30156212",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The Sino-Nasal Outcome Test-22 as a tool to identify chronic rhinosinusitis in adults with cystic fibrosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26228968",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "rden. Our objective was to investigate the utility of the 22-item Sino-Nasal Outcome Test (SNOT-22) as a tool to identify CRS in adults wit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26228968",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated chronic rhinosinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for chronic rhinosinusitis with nas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: The SNOT-22 (22-item Sinonasal Outcome Test) is a high-quality outcome measure that assesses chronic rhinosinusitis-specific quality of lif",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34182821",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: The 22-item sino-nasal outcome test (SNOT-22) is a widely used and powerful patient-reported outcomes measure for chronic rhinosinusitis (CRS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34585521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated chronic rhinosinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for chronic rhinosinusitis with nasal polyps (CRSwNP",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: The 22-item Sino-Nasal Outcome Test (SNOT-22) is a commonly utilized outcome measure for chronic rhinosinusitis (CRS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26610073",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES/HYPOTHESIS: The 22-item Sinonasal Outcome Test (SNOT-22) is a validated chronic rhinosinusitis health-related quality-of-life outcome (HRQoL) measure; however, SNOT-22 domains have not been validated specifically for chronic rhinosinusitis with nasal polyps (CRSwNP).STUDY DESIGN: Validation of SNOT-22 domain structure, using data from 3 randomized, placebo-controlled, double-blinded, multicenter clinical trials of dupilumab in adults with moderate-to-severe CRSwNP.METHODS: Preliminary dimensional structure was derived by exploratory factor analyses of SNOT-22 data from a phase 2 trial (NCT01920",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: We set out to determine the psychometric validation of a disease-specific health related quality of life instrument for use in chronic rhinosinusitis, the 22 item Sinonasal Outcome Test (SNOT-22), a modification of a pre-existing instrument, the SNOT-20.DESIGN, SETTING AND PARTICIPANTS: The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis was a prospective cohort study collecting data on 3128 adult patients undergoing sinonasal sur",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19793277",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: The SNOT-22 (22-item Sinonasal Outcome Test) is a high-quality outcome measure that assesses chronic rhinosinusitis-specific quali",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34182821",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "act of CRS. We sought to determine if 22-item Sino-Nasal Outcome Test (SNOT-22) score is predictive of patient-perceived CRS symptom control.METHODS: Prospective cross-sectional study of 2",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28753732",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Sinonasal Outcome Test (SNOT-22) Is a Poor Diagnostic Tool for Chronic Rhinosinusitis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33657861",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28753732",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "cture with strong Cronbach's alpha values (all >0.80). Moderate-to-high correlations were observed between change in SNOT-22 domain scores and other study patient-reported outcome measures, along with large effect-size estimates (\u22650.7), demonstrating re",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34437720",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}